Articlehybrid2015

Societal costs of diabetes mellitus in Denmark

Camilla Sortsø · A. Green · Peter Bjødstrup Jensen · Martha Emneus

89 citations0/0 files storedDiabetic Medicine

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Health Systems, Economic Evaluations, Quality of Life Diabetes Management and Research Diabetes Treatment and Management

Abstract

AIM: To provide comprehensive real-world evidence on societal diabetes-attributable costs in Denmark. METHODS: National register data are linked on an individual level through unique central personal registration numbers in Denmark. All patients in the Danish National Diabetes Register in 2011 (N = 318 729) were included in this study. Complication status was defined according to data from the Danish National Hospital Register. Diabetes-attributable costs were calculated as the difference between costs of patients with diabetes and the expected costs given the annual resource consumption of the diabetes-free population. RESULTS: Societal costs attributable to diabetes were estimated to be at least 4.27 billion EUR in 2011, corresponding to 14,349 EUR per patient-year. A twofold higher healthcare resource usage was found for patients with diabetes as compared with the diabetes-free population. Attributable costs, grouped according to different components, were 732 million EUR for primary and secondary care services, 153 million EUR for pharmaceutical drugs, 851 million EUR for nursing services, 1.77 billion EUR in lost productivity and 761 million EUR for additional costs. A steep increase in diabetes-attributable costs was found for patients with major complications compared with patients without complications across all cost components. For attributable healthcare costs this increase was estimated to be 6,992 EUR per person-year after controlling for potential confounders. CONCLUSIONS: Nearly half of the total costs of patients with diabetes can be attributed directly to their diabetes. The majority of costs are incurred among patients with major complications pointing to the importance of secondary preventive efforts among patients with diabetes.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 89 citations exist upstream.

References

2005Methods for the Economic Evaluation of Health Care Programmes 2003Economic Costs of Diabetes in the U.S. in 2002 2013Economic Costs of Diabetes in the U.S. in 2012 1994Health care expenditures for people with diabetes mellitus, 1992.2004Cost-of-Illness Studies in Diabetes Mellitus 2014The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)2002The Cost of Diabetes Type II in Europe The CODE-2 Study

Cited by

2017Healthcare costs of Type 2 diabetes in Germany

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.